Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Credit Suisse Reiterates Underperform on Aveanna Healthcare Hldgs, Maintains $1 Price Target

Author: Benzinga Newsdesk | August 11, 2023 09:05am
Credit Suisse analyst A.J. Rice reiterates Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Underperform and maintains $1 price target.

Posted In: AVAH